Welcome to OncologyPRO, the home of Esmo’s educational and scientific resources.

Receipt of total abdominal hysterectomy with chemotherapy may improve survival compared with chemotherapy alone in women with uterine cancer whose disease has spread to distant organs

Axillary adenopathy may be present in women who undergo mammography within 90 days of COVID-19 vaccination

Two years of aromatase inhibitor therapy after initial endocrine treatment provides similar survival outcomes to a 5-year course while reducing the risk of treatment-related bone fracture

Chronic myeloid leukaemia patients are more likely to experience liver enzyme increases during treatment with bosutinib, nilotinib or ponatinib than with imatinib

Adding ipilimumab to nivolumab does not extend overall survival for stage IV squamous non-small-cell lung cancer patients who have progressed after chemotherapy

Lymph node-positive colon cancer patients with tumour deposits have poorer survival than those without

The combination of nivolumab and bempegaldesleukin is tolerable and potentially beneficial for treatment-naïve metastatic melanoma patients

Combining magnetic resonance imaging and standard biopsy techniques may improve detection of clinically significant prostate cancer in men with an elevated prostate-specific antigen level